Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 2
2008 5
2009 4
2010 3
2011 14
2012 16
2013 14
2014 15
2015 22
2016 13
2017 25
2018 19
2019 11
2020 18
2021 12
2022 12
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

177 results

Results by year

Filters applied: . Clear all
Page 1
The evolution of brachytherapy for prostate cancer.
Zaorsky NG, Davis BJ, Nguyen PL, Showalter TN, Hoskin PJ, Yoshioka Y, Morton GC, Horwitz EM. Zaorsky NG, et al. Among authors: showalter tn. Nat Rev Urol. 2017 Jun 30;14(7):415-439. doi: 10.1038/nrurol.2017.76. Nat Rev Urol. 2017. PMID: 28664931 Free PMC article. Review.
In Regard to Shah and Royce.
Janowski EM, Romano KD, Showalter TN. Janowski EM, et al. Among authors: showalter tn. Int J Radiat Oncol Biol Phys. 2021 Aug 1;110(5):1539-1540. doi: 10.1016/j.ijrobp.2021.04.044. Int J Radiat Oncol Biol Phys. 2021. PMID: 34273326 No abstract available.
Editorial Comment.
Showalter TN. Showalter TN. J Urol. 2016 May;195(5):1401-1402. doi: 10.1016/j.juro.2015.11.084. Epub 2016 Jan 28. J Urol. 2016. PMID: 26827848 No abstract available.
A primer on time-driven activity-based costing in brachytherapy.
Mulherkar R, Keller A, Showalter TN, Thaker N, Beriwal S. Mulherkar R, et al. Among authors: showalter tn. Brachytherapy. 2022 Jan-Feb;21(1):43-48. doi: 10.1016/j.brachy.2021.05.008. Epub 2021 Aug 8. Brachytherapy. 2022. PMID: 34376368 Review.
Pan-cancer analysis of prognostic metastatic phenotypes.
Zaorsky NG, Wang X, Garrett SM, Lehrer EJ, Lin C, DeGraff DJ, Spratt DE, Trifiletti DM, Kishan AU, Showalter TN, Park HS, Yang JT, Chinchilli VM, Wang M. Zaorsky NG, et al. Among authors: showalter tn. Int J Cancer. 2022 Jan 1;150(1):132-141. doi: 10.1002/ijc.33744. Epub 2021 Aug 27. Int J Cancer. 2022. PMID: 34287840 Free PMC article.
Postprostatectomy radiation therapy: an evidence-based review.
Mishra MV, Champ CE, Den RB, Scher ED, Shen X, Trabulsi EJ, Lallas CD, Knudsen KE, Dicker AP, Showalter TN. Mishra MV, et al. Among authors: showalter tn. Future Oncol. 2011 Dec;7(12):1429-40. doi: 10.2217/fon.11.120. Future Oncol. 2011. PMID: 22112318 Review.
ACR Appropriateness Criteria® Locally Advanced, High-Risk Prostate Cancer.
McLaughlin PW, Liss AL, Nguyen PL, Assimos DG, D'Amico AV, Gottschalk AR, Gustafson GS, Keole SR, Liauw SL, Lloyd S, Movsas B, Prestidge BR, Showalter TN, Taira AV, Vapiwala N, Davis BJ; Expert Panel on Radiation OncologyProstate. McLaughlin PW, et al. Among authors: showalter tn. Am J Clin Oncol. 2017 Feb;40(1):1-10. doi: 10.1097/COC.0000000000000354. Am J Clin Oncol. 2017. PMID: 28059930
177 results